Per reporter: Cai Ding Per editor: Zhao Qing
Every AI-newsletter, glaxosmithkline PLC said wednesday it was working with Eli Lilly & Co. and vir biotechnology Inc. to evaluate the efficacy of a combination of two COVID-19 therapies in low-risk patients with mild to moderate symptoms of the virus.
Daily economic news
![Interview with GlaxoSke Chishin: With core competitiveness, we will steadily develop the Chinese market[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
On the afternoon of June 28, vaccine giant GlaxoSmithKline (GSK) announced that the herpes zoster vaccine Xinanlishi was officially launched in China for the prevention of shingles in adults aged 50 years and older. ...
11-09
In the context of the covid-19 pandemic, healthcare has ranked among the world's most concerned industries. Thanks to the release of medical consumption demand and the guidance of policies to the medical system, China's great health...
11-09
Zhitong Finance APP learned that GSK (GSK. US) and VirBiotechnology (VIR. US) will provide value to the U.S. next month1...
11-18
The Wall Street Journal reported on November 30 that Pfizer's head of viral vaccine science will leave the pharmaceutical giant to join rival GlaxoSmithKline. At Pfizer and...
12-01
Beijing Business News (reporter Yao Qian) On December 2, GlaxoSmithKline said that preclinical data showed that the company's new crown drug Sotrovimab remained active against Omilon. It is reported that...
12-02
Interface News learned that on December 3, in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2021)" released by the National Medical Security Bureau, Glaxo ...
12-03
GlaxoSmithKline said Thursday that in early tests, its coronavirus antibody drug sotorovimab appears to remain effective against the new mutant strain, Olmikeron. The company...
12-03
News from the Central Broadcasting Network on December 3 today (3rd), the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2021)" released by the National Medical Security Bureau...
12-03
Zhitong Finance APP learned that GSK (GSK. US) said today that the company is working with its U.S. partner VirBiotechnology (VIR....
12-02
Financial Associated Press, December 2, GlaxoSmithKline said that preclinical data show that the company's new crown drug Sotrovaimab is active against Omilon. UK Pharmaceuticals and Medical Products...
12-02
According to Bloomberg reported on Dec. 2, a document shows that preclinical data suggest that the company's covid-19 drug Sotrovaimab is active in all variants of concern, including Aomil...
12-02
How to see the continued pullback in the first quarter? Gülen, Zhao Bei and other celebrities revealed the latest layout ideas of medicine and biology, Finance Associated Press, March 31 (Reporter Zhou Xiaoya) In the first quarter of this year, the overall performance of the market...
03-31
